Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019031990) NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/031990 International Application No.: PCT/RU2018/050089
Publication Date: 14.02.2019 International Filing Date: 30.07.2018
IPC:
C07D 401/14 (2006.01) ,C07D 403/04 (2006.01) ,C07D 471/04 (2006.01) ,C07D 403/12 (2006.01) ,A61K 31/4184 (2006.01) ,A61K 31/437 (2006.01) ,A61K 31/4709 (2006.01) ,A61K 31/4375 (2006.01) ,A61P 35/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
401
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
14
containing three or more hetero rings
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
403
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/167
02
containing two hetero rings
04
directly linked by a ring-member-to-ring- member bond
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
471
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
403
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/167
02
containing two hetero rings
12
linked by a chain containing hetero atoms as chain links
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4164
1,3-Diazoles
4184
condensed with carbocyclic rings, e.g. benzimidazoles
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
4353
ortho- or peri-condensed with heterocyclic ring systems
437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
47
Quinolines; Isoquinolines
4709
Non-condensed quinolines containing further heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
4353
ortho- or peri-condensed with heterocyclic ring systems
4375
the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
ЗАКРЫТОЕ АКЦИОНЕРНОЕ ОБЩЕСТВО «БИОКАД» JOINT STOCK COMPANY "BIOCAD" [RU/RU]; Литер А, д. 34, ул. Связи, п .Стрельна, Петродворцовый район, Санкт-Петербург, Liter A, bld. 34, Svyazi st., Strelna, Petrodvortsoviy district St.Petersburg, 198515, RU
Inventors:
МИНДИЧ, Алексей Леонидович MINDICH, Aleksei Leonidovich; RU
ГОРБУНОВА, Светлана Леонидовна GORBUNOVA, Svetlana Leonidovna; RU
ПОПКОВА, Александра Владимировна POPKOVA, Aleksandra Vladimirovna; RU
ШЕХОВЦОВ, Артем Евгеньевич SHEKHAUTSOU, Artsiom Evgenievich; BY
АЛАФИНОВ, Андрей Иванович ALAFINOV, Andrei Ivanovich; RU
АЛЕШУНИН, Павел Александрович ALESHUNIN, Pavel Aleksandrovich; RU
ЕВДОКИМОВ, Антон Александрович EVDOKIMOV, Anton Aleksandrovich; RU
ЗАВЬЯЛОВ, Кирилл Вадимович ZAVIALOV, Kirill Vadimovich; RU
КАСАТКИНА, Мария Андреевна KASATKINA, Mariia Andreevna; RU
КОЖЕМЯКИНА, Наталья Владимировна KOZHEMYAKINA, Natalia Vladimirovna; RU
КУШАКОВА, Анна Сергеевна KUSHAKOVA, Anna Sergeevna; RU
МАКСИМЕНКО, Елена Александровна MAKSIMENKO, Elena Aleksandrovna; RU
МИШИНА, Мария Сергеевна MISHINA, Mariia Sergeevna; RU
РЕХАРСКИЙ, Михаил Владимирович REKHARSKY, Mikhail Vladimirovich; RU
ЧЕСТНОВА, Анна Юрьевна CHESTNOVA, Anna Jur'evna; RU
ЯКОВЛЕВ, Павел Андреевич IAKOVLEV, Pavel Andreevich; RU
МОРОЗОВ, Дмитрий Валентинович MOROZOV, Dmitry Valentinovich; RU
Agent:
ПОЛУДНИЦЫНА, Галина Владимировна POLUDNICYNA, Galina Vladimirovna; RU
Priority Data:
201712812307.08.2017RU
201810817806.03.2018RU
Title (EN) NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS
(FR) NOUVEAUX COMPOSÉS HÉTÉROCYCLIQUES COMME INHIBITEURS DE CDK8/19
(RU) НОВЫЕ ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ КАК ИНГИБИТОРЫ CDK8/19
Abstract:
(EN) The present invention relates to novel compounds of formula (I), or a pharmaceutically acceptable salt or stereoisomer thereof, which exhibit the properties of a CDK 8/19 inhibitor. The invention also relates to a pharmaceutical composition containing said compounds and to the use thereof as pharmaceutical drugs for treating diseases or disorders.
(FR) La présente invention concerne de nouveaux composés ayant la formule (I) ou leur sel pharmaceutiquement acceptable ou leur stéréoisomère possédant les propriétés de l’inhibiteur CDK8/19, une composition pharmaceutique contenant ces composés et leur utilisation en tant que préparations médicamenteuses pour traiter différentes maladies ou troubles.
(RU) Настоящее изобретение относится к новым соединениям формулы (I): или его фармацевтически приемлемая соль, или его стереоизомер, которые обладают свойствами ингибитора CDK8/19, к фармацевтической композиции, содержащей данные соединения, и их применению в качестве фармацевтических препаратов для лечения заболеваний или нарушений.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Russian (RU)
Filing Language: Russian (RU)